Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 14 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | 2,704,496 | reported | 02 Mar 2026 | tx 318+9,391,475−4,998,544 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | SALE | Vanda Pharmaceuticals Inc. | 156,235 | 8.17 USD | |
| 18 Feb 2026 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 525,000 | 0.00 USD | |
| 07 Aug 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 10,000 | 4.15 USD | |
| 21 May 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 9,519 | 4.40 USD | |
| 21 May 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 481 | 4.39 USD | |
| 16 May 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 20,000 | 4.22 USD | |
| 06 Mar 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 5,000 | 5.01 USD | |
| 06 Mar 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 5,000 | 5.02 USD | |
| 05 Mar 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 5,000 | 5.01 USD | |
| 05 Mar 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 5,000 | 5.03 USD | |
| 01 Mar 2025 | TAX_WITHHOLDING | Vanda Pharmaceuticals Inc. | 95,999 | 4.76 USD | |
| 03 Mar 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 10,000 | 4.71 USD | |
| 28 Feb 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 10,000 | 4.76 USD | |
| 27 Feb 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 10,000 | 4.76 USD | |
| 26 Feb 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 5,000 | 4.75 USD | |
| 26 Feb 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 5,000 | 4.78 USD | |
| 25 Feb 2025 | PURCHASE | Vanda Pharmaceuticals Inc. | 10,000 | 4.46 USD | first after silence |
| 18 Feb 2025 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 450,000 | 0.00 USD | |
| 04 Mar 2024 | SALE | Vanda Pharmaceuticals Inc. | 30,884 | 4.24 USD | |
| 05 Mar 2024 | SALE | Vanda Pharmaceuticals Inc. | 24,288 | 4.13 USD | |
| 16 Feb 2024 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 450,000 | 0.00 USD | |
| 02 Mar 2023 | SALE | Vanda Pharmaceuticals Inc. | 22,426 | 6.23 USD | |
| 03 Mar 2023 | SALE | Vanda Pharmaceuticals Inc. | 22,538 | 6.25 USD | |
| 16 Feb 2023 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 115,000 | 0.00 USD | |
| 16 Feb 2023 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 275,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 25 Feb 2025.